Status:

COMPLETED

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Lead Sponsor:

Warner Chilcott

Conditions:

Osteopenia

Eligibility:

FEMALE

40-55 years

Phase:

PHASE3

Brief Summary

The primary purpose of the protocol is to evaluate the sensitivity of 3D-pQCT (3D-Peripheral Quantitative Computed Tomography) technology to detect minute changes in bone microarchitecture.

Detailed Description

The 3D-pQCT equipment allows the evaluation of changes occurring within the bone at "microarchitecture" level, without the need for invasive bone biopsies. The primary objective is to evaluate the sen...

Eligibility Criteria

Inclusion

  • cessation of menstruation (surgical or natural) between 6 and 36 months prior to study enrollment;
  • osteopenic
  • must have at least 1 evaluable radius and tibia, without history of fracture (traumatic or atraumatic)
  • BMI (body mass index) between 18 and 28 kg/m2 inclusive;

Exclusion

  • history of any generalized bone disease, including hyperparathyroidism, Paget's disease of bone, renal osteodystrophy, or any other acquired or congenital bone disease; or any known condition that would interfere with the assessment of DXA (dual-energy X-ray absorptiometry) at either the lumbar spine (3 non-evaluable lumbar vertebrae at lumbar spine L1 - L4) or the femoral neck.
  • clinical or radiological evidence of osteoporosis, such as atraumatic vertebral compression fracture (\* 20% reduction in anterior-to-posterior or middle-to-posterior height ratio; or 20% reduction of the anterior, middle, and/or posterior height as compared with the adjacent vertebrae) documented by spinal X ray or a history of osteoporosis-related atraumatic fracture of the hip or of the wrist;
  • glucocorticoid-induced osteopenia;
  • previous bisphosphonate therapy;

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

161 Patients enrolled

Trial Details

Trial ID

NCT00386360

Start Date

April 1 2006

End Date

September 1 2009

Last Update

January 11 2012

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Research Facility

Buenos Aires, Buenos Aires, Argentina, C1012AAR

2

Research Facility

Heidelberg, Victoria, Australia, 3081

3

Research Facility

Toronto, Ontario, Canada, M5G 2C4

4

Research Facility

Lyon, Lyon, France